NOVOCARDIO
Novocardio is a high-tech company specializing in the genetic diagnosis of cardiovascular diseases, providing the leading single gene genetic testing and cardiovascular drug genetic testing services.
NOVOCARDIO
Industry:
Biotechnology
Founded:
2016-12-07
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.novocardio.com
Total Employee:
11+
Status:
Closed
Total Funding:
10 M CNY
Similar Organizations
NextVivo
NextVivo is a biotech company developing an immune organoid technology platform.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
TransThera Biosciences
TransThera Biosciences is a biotech company that specializes in the treatment of oncology, cardiovascular, and inflammatory diseases.
Founder
Investors List
Amphora Capital
Amphora Capital investment in Seed Round - Novocardio
